Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks.
about
Melatonin for preventing pre-eclampsiaAngiogenesis-Related Biomarkers (sFlt-1/PLGF) in the Prediction and Diagnosis of Placental Dysfunction: An Approach for Clinical IntegrationSerum screening in first trimester to predict pre-eclampsia, small for gestational age and preterm delivery: systematic review and meta-analysisCombined Screening for Early Detection of Pre-EclampsiaPlacental Protein 13 (PP13) - A Placental Immunoregulatory Galectin Protecting PregnancyExtracellular nucleic acids in maternal circulation as potential biomarkers for placental insufficiencyGalectins: Double-edged Swords in the Cross-roads of Pregnancy Complications and Female Reproductive Tract Inflammation and NeoplasiaAntenatal blood pressure for prediction of pre-eclampsia, preterm birth, and small for gestational age babies: development and validation in two general population cohortsDiagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013).Usefulness of circulating microRNAs for the prediction of early preeclampsia at first-trimester of pregnancyAntenatal telephone support intervention with and without uterine artery Doppler screening for low risk nulliparous women: a randomised controlled trialThe vitamin E-binding protein afamin increases in maternal serum during pregnancyEarly prediction of preeclampsiaAssessment of Foetal DNA in Maternal Blood - A Useful Tool in the Hands of Prenatal Specialists.The vascular endothelial growth factor family in adverse pregnancy outcomes.Antenatal screening for Down syndrome using serum placental growth factor with the combined, quadruple, serum integrated and integrated testsMid-trimester maternal ADAM12 levels differ according to fetal gender in pregnancies complicated by preeclampsia.First-trimester uterine artery Doppler and adverse pregnancy outcome: a meta-analysis involving 55,974 women.A description of the methods of the Nulliparous Pregnancy Outcomes Study: monitoring mothers-to-be (nuMoM2b).Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsiaFirst-trimester uterine artery Doppler analysis in the prediction of later pregnancy complicationsTNF-R1 as a first trimester marker for prediction of pre-eclampsia.Pre-eclampsia Diagnosis and Treatment Options: A Review of Published Economic Assessments.Maternal Serum Screening Markers and Adverse Outcome: A New PerspectivePrenatal Screening Using Maternal MarkersEvaluation of serum β-hCG and PAPP-A levels in pregnant women at risk of developing preeclampsia.Expression profile of C19MC microRNAs in placental tissue in pregnancy-related complications.Inflammatory and Other Biomarkers: Role in Pathophysiology and Prediction of Gestational Diabetes Mellitus.Extensive shift in placental transcriptome profile in preeclampsia and placental origin of adverse pregnancy outcomesBlood pressure change in normotensive, gestational hypertensive, preeclamptic, and essential hypertensive pregnancies.Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia.Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion.Early detection of maternal risk for preeclampsiaFirst Trimester Urine and Serum Metabolomics for Prediction of Preeclampsia and Gestational Hypertension: A Prospective Screening StudyPreeclampsia - Aetiology, Current Diagnostics and Clinical Management, New Therapy Options and Future Perspectives.First-trimester prediction of preterm birth using ADAM12, PAPP-A, uterine artery Doppler, and maternal characteristics.Effectiveness and safety of 1 vs 4 h blood pressure profile with clinical and laboratory assessment for the exclusion of gestational hypertension and pre-eclampsia: a retrospective study in a university affiliated maternity hospitalTiming of ischemic insult alters fetal growth trajectory, maternal angiogenic balance, and markers of renal oxidative stress in the pregnant rat.Biomarker development for presymptomatic molecular diagnosis of preeclampsia: feasible, useful or even unnecessary?Placental DNA methylation at term reflects maternal serum levels of INHA and FN1, but not PAPPA, early in pregnancy
P2860
Q24188340-D0712E03-8EE9-42EB-A989-A3EAC9FA5D7FQ26796661-B0592888-29D1-494C-94D4-EDD0D8BFEC73Q26798011-5E12DFC2-8202-4AEB-AACD-9ED87FA3C1F9Q26801503-805F746D-0F32-47CE-B8F2-1CD67C1E55ADQ26861380-1C94B98A-4A41-4967-8E6D-0C9F54B66112Q27012889-F9DBD223-A066-4B6A-A41A-8B0D87396737Q28081459-319D5C7F-4347-42DB-8E7F-65B4E591A42EQ28607419-CB1AEF2F-1AB0-4D52-BC75-D25759280A8FQ33579089-378FF05B-F756-49B7-BE8B-8B225F9201BAQ33581738-E9BE792D-CDEC-4FCD-AEB4-0EEAC01CC638Q33611791-9E5C4858-6CAD-49C1-B5A1-BAFF187E862AQ33786230-0FD08A95-B2F4-49A9-BF4F-B96D471B134FQ34022344-89C50F7E-7998-4F19-822A-023CCE32FF91Q34209281-B14F604C-0EF3-4A8A-9EE3-39C53DD9728EQ34267491-4E355E3B-D51A-4A5C-96A9-E631AC60F5DDQ34442579-59C2731B-AAD0-441C-B6A4-D976E09AB894Q34876147-8C5102E9-099D-42D2-84F3-BB64FD0F559EQ35067015-2423FBFD-D0D5-4C85-934D-3A490CD4534BQ35287430-D20EDC8E-1281-42FF-977A-FECB77D5549DQ35542826-FE8EDC6B-1AEF-4BC3-9A1D-C5F408788558Q35564184-A23DC23C-FD04-4FF8-AD53-4EB3A5BFA6D3Q35574857-2149564A-8153-447B-98BC-49AB15232DA5Q35655056-CCA8E79C-9AC9-4934-8663-4E252D6DCAA4Q35667145-21D7D81B-FD52-40AC-A56C-2D6D952B0A7CQ35667300-EC885863-7FA3-40A1-800D-A6C65E269300Q35714000-A24D3353-50F8-47BF-93CA-826990F7EDFDQ35800606-D044FB05-49E4-4DED-A8FC-50730DD4CBE9Q35814036-121ECC11-7CF1-4A51-9C2D-4303BFD63AE5Q35974526-3560B5E1-E4E6-4665-877B-7F5EA0E1A60DQ36043770-ACEBF32B-735E-49CE-BA49-00D40F535AD9Q36062460-3A8FA51F-06A2-4385-BF70-DCB91307C46DQ36107337-B86F63B1-7899-49BE-B53A-BC1682549010Q36125098-7EDD2889-5346-4102-98CA-E80D5AA6F948Q36184116-8D2525AB-6175-459F-A1F9-44BFC7322E20Q36295102-0D7D10D8-E630-4F55-A420-094FD1652721Q36295872-1FC03280-75E0-4691-A769-2BDAC5125E6FQ36302931-C966C9B6-F048-4DE1-BA4E-40F97539DD32Q36309225-7912DADA-57A5-4460-B6A2-C32B0771EE1AQ36357099-D28D5731-8A8E-440B-BE5F-94969AF8DBE1Q36366144-EB45A780-C320-4552-8C07-65F0E78E26ED
P2860
Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Prediction of early, intermedi ...... emical markers at 11-13 weeks.
@en
Prediction of early, intermedi ...... emical markers at 11-13 weeks.
@nl
type
label
Prediction of early, intermedi ...... emical markers at 11-13 weeks.
@en
Prediction of early, intermedi ...... emical markers at 11-13 weeks.
@nl
prefLabel
Prediction of early, intermedi ...... emical markers at 11-13 weeks.
@en
Prediction of early, intermedi ...... emical markers at 11-13 weeks.
@nl
P2093
P356
P1433
P1476
Prediction of early, intermedi ...... emical markers at 11-13 weeks.
@en
P2093
Kypros H Nicolaides
Mona Zvanca
Ranjit Akolekar
Rita Sarquis
P2860
P356
10.1002/PD.2660
P577
2011-01-01T00:00:00Z